Observed arrival · 2026-10-11
Pathlight makes disease research legible—with caveats attached
A French-language health information service that summarizes research publications, clinical trials and EMA decisions for patients, relatives and clinicians.
- For
- Patients, relatives, clinicians and physiotherapists
- Worth noticing
- Its SUNFISH example names a 180-participant, double-blind, placebo-controlled phase III trial, while flagging modest average benefit and sponsor funding.
Field notes
The landing page describes a daily review of PubMed publications, ClinicalTrials.gov records and European Medicines Agency decisions, with updates filtered by disease and interpreted by audience. Its SUNFISH example identifies a 180-person randomized phase III study, then states the average motor benefit was modest and notes one-year follow-up and industry funding. Spinal muscular atrophy, Duchenne muscular dystrophy and Parkinson’s are marked available; several other conditions are labeled in preparation.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
One card from the complete issue